Applied Immunohistochemistry & Molecular Morphology, published by Lippincott Williams & Wilkins, stands as a pivotal resource within the fields of histology, medical laboratory technology, and pathology. With an ISSN of 1541-2016 and an E-ISSN of 1533-4058, this journal has been contributing significant research and advancements since its inception in 1996. It serves a diverse audience, including researchers, professionals, and students, aiming to enhance the understanding of immunohistochemical techniques and molecular morphology. Recognized for its quality, it holds category quartiles of Q3 in histology and Q2 in medical laboratory technology and pathology and forensic medicine as of 2023. The journal's rigorous peer-review process ensures that only the most impactful findings are disseminated, thus advancing the education and practice in these critical domains of study. Though it is not an open-access journal, it remains essential for keeping abreast of the latest methodological innovations and applications in pathology and laboratory science, as evidenced by its respectable Scopus rankings and the continual convergence of groundbreaking research published through 2024.

The Journal of Hematopathology, published by SPRINGER HEIDELBERG, serves as a vital resource in the fields of hematology, histology, and pathology. Established in 2008, this peer-reviewed journal aims to foster the exchange of knowledge among researchers, clinicians, and students by publishing original articles, reviews, and case studies that contribute to the understanding of hematopathological disorders. While the journal currently ranks in the fourth quartile in various categories including hematology and histology, it positions itself as a platform for emergent research and insights, addressing the evolving landscape of blood-related diseases. Although not an open access journal, it provides crucial access to research findings for professionals looking to stay abreast of developments in pathologic diagnostics and therapeutic strategies. As it continues to grow, the journal remains committed to enhancing the knowledge base and scientific discourse in hematopathology.

Sovremennye Tehnologii v Medicine is a prominent academic journal dedicated to the exploration and dissemination of contemporary technologies in the field of medicine. Published by the esteemed Nizhniy Novgorod State Medical Academy, this journal serves as a vital platform for researchers, healthcare professionals, and students seeking to stay at the forefront of advancements in biochemistry, genetics, and molecular biology. With an impact factor that positions it within the Q3 quartile for both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023, it highlights a commitment to quality research. The journal, identified by the ISSN 2076-4243, provides a rich repository of knowledge for those interested in the innovative applications of medical science, contributing significantly to the academic discourse and the practical world of healthcare. With an open access option, it ensures that its valuable content is readily accessible to a global audience, fostering collaborative advancements in modern medical practices.

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, an esteemed journal published by VIA MEDICA, serves as a vital platform for researchers and professionals in the fields of histology, pathology, and cytobiology. With an ISSN of 0239-8508 and E-ISSN of 1897-5631, this Open Access journal has been disseminating significant findings since 1984, offering free access to a broad audience of scientists and academics. Based in Poland, this journal focuses on critical advancements in the study of cellular structures and functions, contributing substantially to the understanding of various diseases and biological processes. The journal currently holds a respectable impact factor, ranking in the Q3 category for Histology and miscellaneous Medicine, and Q2 for Pathology and Forensic Medicine as per the 2023 metrics. With its commitment to quality research and an inclusive publishing approach, FOLIA HISTOCHEMICA ET CYTOBIOLOGICA is poised to continue influencing its fields significantly through 2024 and beyond.

The Journal of Molecular Histology, published by Springer, stands at the forefront of multidisciplinary research in cellular and molecular histology, offering vital contributions in the fields of Cell Biology, Histology, and Medicine. With an ISSN of 1567-2379 and an E-ISSN of 1567-2387, this peer-reviewed journal has maintained its commitment to advancing knowledge since its inception in 2004 and continues to thrive into 2024. The journal, located in The Netherlands, boasts a robust impact within its categories, currently holding Q3 rankings in Cell Biology and Q2 rankings in Histology, Medicine, and Physiology, highlighting its relevance to academics and professionals alike. With Scopus rankings that reflect a strong percentile presence across multiple fields, the journal emphasizes open access options to enhance the dissemination of critical research findings. As a valuable resource for researchers, professionals, and students engaged in molecular exploration, the Journal of Molecular Histology fosters innovation and collaboration, making significant impacts on our understanding of tissue structure and function.

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

ULTRASTRUCTURAL PATHOLOGY is a prestigious academic journal published by Taylor & Francis Inc, focusing on the intricate and detailed aspects of pathology as well as forensic medicine since its inception in 1980. With an ISSN of 0191-3123 and an E-ISSN of 1521-0758, this journal provides a vital platform for researchers and professionals to disseminate innovative findings pertinent to both clinical and experimental pathology. Despite not being an open-access journal, its contributions are critical within its categories, positioned at the Q3 quartile in Pathology and Forensic Medicine and Q4 in Structural Biology as of 2023. The journal's reputation is further underscored by its Scopus rankings, placing it in the 41st percentile for Pathology and 15th percentile for Structural Biology, indicating a competitive standing in these fields. ULTRASTRUCTURAL PATHOLOGY aims to foster rigorous scholarly discourse and advance knowledge through the publication of original research articles, reviews, and case studies, making it an essential resource for academics, practitioners, and students engaged in the evolving domains of pathology and structural biology.